Mark Chen Selected Research

Mark Chen Research Topics

Disease

15	Neoplasms (Cancer) 07/2022 - 11/2004
4	Sarcoma (Soft Tissue Sarcoma) 10/2021 - 10/2017
4	Inflammation (Inflammations) 01/2014 - 08/2008
3	Myxoid Liposarcoma 10/2021 - 01/2019
3	Human Influenza (Influenza) 01/2019 - 06/2010
2	COVID-19 01/2022 - 01/2021
2	Brain Neoplasms (Brain Tumor) 01/2021 - 07/2009
2	Disease Progression 01/2021 - 01/2013
2	Glioma (Gliomas) 01/2021 - 11/2004
2	Neurofibrosarcoma (MPNST) 01/2020 - 01/2018
2	Liver Neoplasms (Liver Cancer) 03/2011 - 07/2009
1	Melanoma (Melanoma, Malignant) 07/2022
1	Infections 02/2022
1	Carcinogenesis 10/2021
1	Genetic Translocation (Chromosomal Translocation) 10/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Diffuse Intrinsic Pontine Glioma 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Genomic Instability 01/2019
1	Fatty Liver 01/2014
1	Otitis Media 01/2014
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2014
1	Edema (Dropsy) 07/2012
1	Alzheimer Disease (Alzheimer's Disease) 07/2012
1	Carcinoma (Carcinomatosis) 03/2011
1	Breast Neoplasms (Breast Cancer) 07/2009
1	Gliosarcoma 03/2006

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 01/2020 - 08/2008
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2022 - 01/2018
2	Oncogene Proteins (Oncogene Protein)IBA 10/2021 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 03/2011
2	VaccinesIBA 01/2019 - 06/2010
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2009 - 03/2009
1	Immune Checkpoint InhibitorsIBA 07/2022
1	Neutralizing AntibodiesIBA 02/2022
1	Viral RNAIBA 01/2022
1	AerosolsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 10/2021
1	PrionsIBA 10/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	dipinacoline glutamateIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	Sodium-Hydrogen Exchanger 3IBA 11/2019
1	F-Box-WD Repeat-Containing Protein 7IBA 11/2019
1	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2019
1	TrabectedinIBA 03/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	trametinibIBA 01/2018
1	capmatinibIBA 01/2018
1	Site-specific recombinaseIBA 10/2017
1	Cre recombinaseIBA 10/2017
1	Recombinases (Recombinase)IBA 07/2017
1	Small Interfering RNA (siRNA)IBA 07/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	Neuraminidase (Sialidase)IBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	SuspensionsIBA 01/2014
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 01/2014
1	Triglycerides (Triacylglycerol)IBA 01/2014
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2014
1	EicosanoidsIBA 01/2014
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2014
1	Oseltamivir (Tamiflu)FDA Link 01/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2013
1	Amyloid (Amyloid Fibrils)IBA 07/2012
1	Apolipoprotein E4IBA 07/2012
1	NanodiamondsIBA 03/2011
1	CytokinesIBA 10/2009
1	6- ((3- chloro)anilino)- 2- (isopropyl- 2- hydroxyethylamino)- 9- isopropylpurineIBA 07/2009
1	afimoxifene (hydroxytamoxifen)IBA 07/2009
1	DiamondIBA 03/2009
1	Collagen Type I (Type I Collagen)IBA 03/2009
1	MicellesIBA 08/2008
1	Vascular Endothelial Growth Factor DIBA 03/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2006
1	Biomarkers (Surrogate Marker)IBA 03/2006
1	NucleotidesIBA 11/2004
1	EnzymesIBA 11/2004
1	ProdrugsIBA 11/2004
1	uracil phosphoribosyltransferaseIBA 11/2004
1	Cytosine DeaminaseIBA 11/2004
1	Fluorouracil (Carac)FDA LinkGeneric 11/2004

Therapy/Procedure

6	Therapeutics 07/2022 - 11/2004
4	Radiotherapy 10/2021 - 01/2019
1	Molecular Targeted Therapy 07/2022
1	Immunotherapy 07/2022
1	Length of Stay 01/2021
1	Ambulatory Care (Outpatient Care) 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Extracorporeal Membrane Oxygenation 01/2014
1	Salvage Therapy 01/2014